Clinical Trial Results: Positive outcomes in TNXP's clinical trials for its pipeline drugs, particularly Tonmya for fibromyalgia, typically drive the stock price up. Conversely, negative results or trial failures often lead to a price decrease.

Regulatory Approvals: Receipt of FDA approval for any of TNXP's drug candidates will likely cause a significant spike in the stock price. Delays or rejections in the approval process can have the opposite effect.

Financial Performance: TNXP's cash reserves, burn rate, and ability to secure funding (through grants, partnerships, or equity offerings) impact investor confidence. A strong financial position typically stabilizes or increases the stock price, while financial instability can depress it.

Market Sentiment: Overall market conditions and investor sentiment towards biotech and pharmaceutical stocks can influence TNXP's stock price. Positive market trends generally lift the stock, while negative trends can pressure it.

Competition: The competitive landscape for TNXP's target indications, such as fibromyalgia and PTSD, plays a role. The emergence of new, potentially superior treatments from competitors could negatively impact TNXP's prospects and stock price.

Partnerships and Collaborations: Strategic partnerships with other pharmaceutical companies or research institutions can boost investor confidence and increase the stock price. These collaborations often provide financial resources and validation of TNXP's technology.

News and Media Coverage: Positive media coverage and analyst ratings can attract new investors and drive up the stock price. Conversely, negative news or downgrades can lead to a sell-off.

Management Team: The experience and credibility of TNXP's management team are important factors. A strong, experienced leadership team can inspire investor confidence, while concerns about management can negatively impact the stock.

Pipeline Progress: Advancements in TNXP's drug development pipeline, such as moving drug candidates into later-stage clinical trials, can positively affect the stock price. Stagnation or setbacks in the pipeline can have the opposite effect.

Patent Protection: The strength and breadth of TNXP's patent portfolio are crucial for protecting its intellectual property and maintaining a competitive advantage. Weaknesses in patent protection can raise concerns and negatively affect the stock price.